Clinical Efficacy and Safety Evaluation of Irbesartan and Amlodipine Combined Therapy in Essential Hypertension Patients

Clinical trial NCT05476354 · COMPLETED

Trial details

NCT number: NCT05476354
Sponsor: Handok Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Essential Hypertension

Start date: 2022-07-05
Primary completion: 2023-04-03
Enrollment: 271

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.